Nuclear medicine in India is growing rapidly. India is the only country, which offers high end PET-CT scans to our population at extremely low cost at several government hospitals, says Dr Vikram Lele, Director, Department of Nuclear Medicine & PET CT, Jaslok Hospital & Research Centre, Mumbai
Healthcare market in India visa- vis the global market
Healthcare market in India is growing rapidly. We now have capability of offering world class facilities at lesser cost than developed countries.
Your current operations and expansion plans.
Jaslok hospital and Research centre is a pioneering private hospital in India with over 40 years of existence. It provides state-of-the-art, cutting edge diagnostics, and therapeutic facilities. New satellite centres are being planned. The Department of Nuclear Medicine at Jaslok is considered amongst the leading departments in India offering training for DNB in nuclear medicine. It is among the best equipped centres in India in terms of technology and staff.
What are your views on the price sensitivity of the Indian market, and how does your diagnostic counter this problem?
Indian market is very price sensitive. The trade-off between providing high quality state-of-the-art diagnostics and therapeutic facilities at affordable cost is a difficult balancing act. Providing packages tailored for specific medical conditions is how our hospital attempts to face this issue.
What are your views on government regulation or any other challenges faced while operating the Indian market?
The speciality of nuclear medicine is very strictly regulated by the Atomic Energy Regulatory Board of the Government of India. No such strict regulations exist for radiology practice. While this attempts to maintain quality control over nuclear medicine practice, over regulation also tends to stifle the growth and spread of the speciality to Indian cities depriving major chunk of our population of its benefits.
Please comment on emerging trends and new technologies.
In nuclear medicine, emerging trends are for fusion imaging wherein CT and MRI are combined with a nuclear medicine scanner in one machine to give a very powerful diagnostic tool: PET-CT and PET-MR. Targeted therapies for neuroendocrine cancers, lymphomas, and thyroid cancer using radioisotopes are emerging as powerful effective therapeutic options.
What are your hospitals offerings?
The Department of Nuclear medicine, Jaslok hospital offers every possible diagnostic and therapeutic Nuclear medicine procedure which is being done at major hospitals abroad. Targeted therapies for neuroendocrine cancer (Peptide Receptor Radionuclide Therapy) are being offered at half the cost as compared to abroad.